405
Views
4
CrossRef citations to date
0
Altmetric
Editorials: Cell Cycle Features

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression

, &
Pages 633-634 | Received 07 Dec 2012, Accepted 13 Dec 2012, Published online: 15 Feb 2012

Figures & data

Figure 1 Potential crosstalk among Ras, PKCζ/PKCδ and the mTOR signaling pathway(s) regulating calcineurin inhibitor (CNI)-induced VEGF overexpression in renal cancer cells. Following CNI treatment, the Ras-PKC pathway becomes activated and promotes transcriptional activation of VEGF through the transcription factor Sp1. Carabin may play a significant role in CNI-induced Ras activation. CNI-induced and Ras-PKC-mediated signals can also be channeled through mTOR for the regulation of VEGF expression; Ras- and PKC (PKCζ/PKCδ)-mediated signals can promote the activation mTOR complex1 (mTORC1). Together, mTOR may act as a critical intermediary signaling molecule for CNI-induced VEGF overexpression in renal cancer cells.

Figure 1 Potential crosstalk among Ras, PKCζ/PKCδ and the mTOR signaling pathway(s) regulating calcineurin inhibitor (CNI)-induced VEGF overexpression in renal cancer cells. Following CNI treatment, the Ras-PKC pathway becomes activated and promotes transcriptional activation of VEGF through the transcription factor Sp1. Carabin may play a significant role in CNI-induced Ras activation. CNI-induced and Ras-PKC-mediated signals can also be channeled through mTOR for the regulation of VEGF expression; Ras- and PKC (PKCζ/PKCδ)-mediated signals can promote the activation mTOR complex1 (mTORC1). Together, mTOR may act as a critical intermediary signaling molecule for CNI-induced VEGF overexpression in renal cancer cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.